Chugai Pharma to Reduce Tamiflu Supply By Half This Winter (Japan)
This article was originally published in PharmAsia News
Executive Summary
Chugai Pharmaceutical, the Japanese distributor of Tamiflu, has announced it will only supply the country with 6 million doses of the flu vaccine. That is only half of the 12 million doses the company supplied last year. The company says the cut is due to a report by the Japanese Health Ministry released in March. The report apparently advised against administering the drug to teenagers because of possible behavioral side effects. Although no concrete evidence of this connection has been found, Chugai announced that both teens and adults may shy away from the vaccine in light of the report. (Click here for more - May Require Paid Subscription